Literature DB >> 25690725

Toxic epidermal necrolysis triggered by clobazam: a case report in a 13-year-old girl.

Chuong D Dang1, Linda Beets-Shay2, Estelle C Kahn2.   

Abstract

We present a case of toxic epidermal necrolysis (TEN) triggered by clobazam in a 13-year-old girl who was subsequently treated with intravenous immunoglobulin. In December 2013 the U.S. Food and Drug Administration released a warning that clobazam might cause "serious skin reactions" such as Stevens-Johnson syndrome or TEN and approved label changes.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25690725     DOI： 10.1111/pde.12527

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  4 in total

1.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Authors:  Noel Frey; Michael Bodmer; Andreas Bircher; Susan S Jick; Christoph R Meier; Julia Spoendlin
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

2.  PharmGKB summary: clobazam pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Steven Leeder; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2018-04       Impact factor: 2.089

Review 3.  The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.

Authors:  Paul LaPenna; Laura M Tormoehlen
Journal:  J Med Toxicol       Date:  2017-08-16

Review 4.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.